Health economics

Pharma/medtech products cannot be successful without a favourable cost-effectiveness and budget impact profile. Upon completion of this course, you will master the fundamentals of health economic evaluations as a non-health-economist, and add value to decisions and communications related to products in R&D and/or brands in the market.

Most countries have their own Health Technology Assessment (HTA) body with specific views about which criteria to be used and how the HTA process should be conducted. On top of that, EU-level networks strive for a more efficient use of resources and increased collaboration between all stakeholders involved. In this 1-day course you will learn how companies should optimise processes and criteria in this complex environment.